Latigo Biotherapeutics, Inc. (LTGO)
12.66
-0.35
(-2.69%)
USD |
NASDAQ |
Nov 06, 10:12
Latigo Biotherapeutics Total Liabilities (Quarterly) : 52.26M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 52.26M |
| Date | Value |
|---|---|
| March 31, 2026 | 14.58M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Turn Therapeutics, Inc. | 16.27M |
| Journey Medical Corp. | 66.24M |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 200.29M |
| Veru, Inc. | 8.651M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 64.76M |
| Shareholders Equity (Quarterly) | 12.50M |
| Debt to Equity Ratio | 2.500 |
| Current Ratio | 1.148 |